C World Wide Group Holding A Exact Sciences Corp Transaction History

C World Wide Group Holding A

$8.2 Billion
Q4 2024

A detailed history of C World Wide Group Holding A transactions in Exact Sciences Corp stock. As of the latest transaction made, C World Wide Group Holding A holds 836,618 shares of EXAS stock, worth $44.8 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

836,618

Previous 1,500,829 44.26%

Holding current value

$44.8 Million

Previous $102 Million 54.02%

% of portfolio

0.57%

Previous 1.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$49.33 - $71.97 $32.8 Million - $47.8 Million	-664,211 Reduced 44.26%	836,618 $47 Million
Q3 2024 Nov 05, 2024	SELL	$42.43 - $70.83 $149,608 - $249,746	-3,526 Reduced 0.23%	1,500,829 $102 Million
Q2 2024 Jul 31, 2024	BUY	$41.33 - $74.26 $15.1 Million - $27.2 Million	366,385 Added 32.2%	1,504,355 $63.6 Million
Q1 2024 May 03, 2024	BUY	$56.27 - $73.77 $28.5 Million - $37.3 Million	505,797 Added 80.01%	1,137,970 $78.6 Million
Q3 2023 Nov 03, 2023	SELL	$65.94 - $99.04 $2.62 Million - $3.93 Million	-39,673 Reduced 5.91%	632,173 $43.1 Million
Q2 2023 Aug 02, 2023	SELL	$62.68 - $95.05 $1.04 Million - $1.57 Million	-16,552 Reduced 2.4%	671,846 $63.1 Million
Q1 2023 May 02, 2023	BUY	$47.19 - $70.77 $3.29 Million - $4.93 Million	69,706 Added 11.27%	688,398 $46.7 Million
Q4 2022 Feb 03, 2023	SELL	$30.35 - $53.15 $6,130 - $10,736	-202 Reduced 0.03%	618,692 $30.6 Million
Q3 2022 Nov 03, 2022	BUY	$31.97 - $49.37 $5.43 Million - $8.39 Million	170,000 Added 37.87%	618,894 $20.1 Million
Q2 2022 Aug 02, 2022	BUY	$35.61 - $76.23 $3.87 Million - $8.29 Million	108,689 Added 31.95%	448,894 $17.7 Million
Q1 2022 May 04, 2022	BUY	$57.56 - $82.54 $452,651 - $649,094	7,864 Added 2.37%	340,205 $23.8 Million
Q4 2021 Feb 02, 2022	BUY	$72.5 - $100.68 $4.99 Million - $6.94 Million	68,889 Added 26.15%	332,341 $25.9 Million
Q3 2021 Nov 01, 2021	BUY	$90.24 - $124.05 $82,208 - $113,009	911 Added 0.35%	263,452 $25.1 Million
Q2 2021 Aug 04, 2021	BUY	$93.66 - $139.27 $531,707 - $790,635	5,677 Added 2.21%	262,541 $32.6 Million
Q1 2021 May 04, 2021	SELL	$116.57 - $155.01 $3.5 Million - $4.65 Million	-30,000 Reduced 10.46%	256,864 $33.9 Million
Q4 2020 Feb 05, 2021	SELL	$99.61 - $142.12 $9.46 Million - $13.5 Million	-95,000 Reduced 24.88%	286,864 $38 Million
Q3 2020 Nov 02, 2020	BUY	$72.92 - $102.01 $6.73 Million - $9.41 Million	92,234 Added 31.85%	381,864 $38.9 Million
Q2 2020 Aug 05, 2020	SELL	$55.75 - $92.75 $2.51 Million - $4.17 Million	-45,000 Reduced 13.45%	289,630 $25.2 Million
Q1 2020 May 04, 2020	BUY	$37.9 - $104.44 $5.9 Million - $16.3 Million	155,698 Added 87.02%	334,630 $19.4 Million
Q2 2019 Aug 02, 2019	BUY	$89.51 - $118.04 $10.7 Million - $14.2 Million	120,000 Added 203.62%	178,932 $21.1 Million
Q1 2019 May 03, 2019	SELL	$61.98 - $96.5 $582,550 - $907,003	-9,399 Reduced 13.76%	58,932 $5.11 Million
Q4 2018 Feb 12, 2019	SELL	$56.04 - $82.66 $1.36 Million - $2 Million	-24,241 Reduced 26.19%	68,331 $4.31 Million
Q3 2018 Nov 05, 2018	SELL	$48.29 - $80.6 $971,932 - $1.62 Million	-20,127 Reduced 17.86%	92,572 $7.31 Million
Q2 2018 Aug 03, 2018	BUY	$37.84 - $69.96 $908,387 - $1.68 Million	24,006 Added 27.07%	112,699 $6.74 Million
Q1 2018 May 03, 2018	BUY	$39.82 - $57.53 $612,551 - $884,983	15,383 Added 20.98%	88,693 $3.58 Million
Q4 2017 Feb 07, 2018	SELL	$46.49 - $60.51 $3.71 Million - $4.83 Million	-79,820 Reduced 52.13%	73,310 $3.85 Million
Q3 2017 Nov 06, 2017	BUY	$37.05 - $47.12 $5.67 Million - $7.22 Million	153,130	153,130 $7.22 Million

Others Institutions Holding EXAS

# of Institutions

660

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.47B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

News

Stay updated on C World Wide Group Holding A with notifications on news.

Account

C World Wide Group Holding A Exact Sciences Corp Transaction History